Save Time and Money with ExyCell®

Infinitely configurable biomanufacturing environments that provide all the benefits of standardization without sacrificing customization. Best of all, operators will enjoy wide-open spaces to work comfortably with greater productivity.

Activate Youtube video
To view the Youtube video, please accept the marketing cookies. For more information, please see our privacy policy.
Change cookie settings

Why clients choose ExyCell

ExyCell’s pre-configured and pre-fabricated modules reduce the design and construction effort, thereby shortening time to market for new drugs and vaccines. The standardized approach reduces risk and ensures cost certainty.


Tailored to clients’ needs

  • The design is adaptable to any process layout and manufacturing requirements including cGMP.
  • Third-party equipment can be selected independently.
  • Modularity enables a rapid capacity expansion of the plant and an accelerated market entry.

Facilities as greenfield projects

The construction of the main building and cleanrooms based on ExyCell modules takes place in parallel rather than in sequence, accelerating the project schedule by up to 50%.

Construction as a retrofit building

Any existing building, such as a warehouse, can be upgraded to a state-of-the-art biomanufacturing facility by integrating ExyCell modules. 

Better than traditional stick-built pharma cleanrooms

  • Applicable for biotechnological manufacturing processes, such as monoclonal antibodies, vaccines, viral vectors, and ATMPs* as well as for the fill & finish of the corresponding drug products
  • Modules fit to standard container size, avoiding expensive special transports
  • Adjustable height to accommodate large equipment

* ATMP refers to Advanced Therapy Medicinal Products, also known as Medicinal Products for Cell and Gene Therapies 


Exyte empowers the biopharmaceutical industry

Exyte has successfully completed the construction of the first ExyCell® facility in China, the CliniMACS Cell Factory® of Miltenyi Biotec, a global provider of integrated solutions for Advanced Therapy Medical Products (ATMPs).

Activate Youtube video
To view the Youtube video, please accept the marketing cookies. For more information, please see our privacy policy.
Change cookie settings

The patented ExyCell technology was developed by Exyte as an end-to-end, integrated facility solution with standardized and modularized elements. These pre-configured and pre-fabricated modules enable fast-track construction thereby shortening time-to-market for new therapeutics and vaccines. The ExyCell facility is installed on the fourth floor of the ATLATL building located in the Zhangjiang High-Tech Park, and Miltenyi Biotec is now transferring production technology from Germany to China with regular operations for ATMP production is expected by autumn 2021. The facility will soon be open to visitors by appointment.

Read more

Contact us

If you would like to know how ExyCell can improve your business, do not hesitate to send an email to info.bls(at) - we are happy to get in touch!


“Our open ballroom concept with cells allows standard arrangements that can be assembled in different ways for virtually any layout.” 

Luca Mussati,
Vice President of Pharmaceuticals and Biotechnology


Technology Partners

Univercells Technologies

Press Release "Exyte and Univercells Technologies combine forces for rapid deployment of vaccine production plants in the wake of the COVID-19 pandemic"


Press release "Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities"